+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
The Medicines Company - logo

The Medicines Company aims to be a leader in the areas of serious infectious disease care, acute cardiovascular care, and surgery and perioperative care. Its marketed products include Angiomax, an anticoagulant used during coronary angioplasties; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; and Ionsys for the short-term management of acute postoperative pain. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.

From
MRSA Drugs - Global Strategic Business Report - Product Thumbnail Image

MRSA Drugs - Global Strategic Business Report

  • Report
  • April 2024
  • 183 Pages
  • Global
From
From
Cardiovascular Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2024

  • Report
  • April 2024
  • 300 Pages
  • Global
From
Bacterial Pneumonia - Pipeline Insight, 2024 - Product Thumbnail Image

Bacterial Pneumonia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Acute Coronary Syndrome: Global Strategic Business Report - Product Thumbnail Image

Acute Coronary Syndrome: Global Strategic Business Report

  • Report
  • April 2024
  • 182 Pages
  • Global
From
Anti-Platelet Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Platelet Agents - Global Strategic Business Report

  • Report
  • April 2024
  • 94 Pages
  • Global
From
mRNA Therapeutics and Vaccines: Key Opinion Leaders - Product Thumbnail Image

mRNA Therapeutics and Vaccines: Key Opinion Leaders

  • Report
  • September 2021
  • 116 Pages
  • Global
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
From
Acute Coronary Syndrome Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Acute Coronary Syndrome Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 635 Pages
  • Global
From
Antibiotic Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Antibiotic Collaboration and Licensing Deals 2016-2023

  • Report
  • November 2023
  • 100 Pages
  • Global
From
Disease Analysis: Dyslipidemia - Product Thumbnail Image

Disease Analysis: Dyslipidemia

  • Report
  • November 2020
  • 101 Pages
  • Global
Inclisiran - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Inclisiran - Emerging Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Inclisiran - Product Thumbnail Image

Inclisiran

  • Report
  • June 2018
  • 17 Pages
  • Global
From
Asthma - Competitive landscape, 2023 - Product Thumbnail Image

Asthma - Competitive landscape, 2023

  • Report
  • April 2023
  • 240 Pages
  • Global
From
Melanoma Treatment Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Melanoma Treatment Market - Forecasts from 2022 to 2027

  • Report
  • May 2022
  • 120 Pages
  • Global
From
From
Loading Indicator